About 1 in 31 children in the United States, or 3.2%, have been identified with autism spectrum disorder, based on 2022 surveillance data from the CDC. Globally, the estimate is lower at roughly 1 in 127 people, reflecting wide differences in how countries screen for and diagnose autism.
Current U.S. Prevalence in Children
The CDC tracks autism rates through its Autism and Developmental Disabilities Monitoring (ADDM) Network, which collects data from 16 sites across the country. The most recent report, based on 8-year-old children born in 2014, found a combined prevalence of 32.2 per 1,000 children. That 3.2% figure is the highest the network has ever recorded.
Rates vary dramatically by location. In Laredo, Texas, just 1% of 8-year-olds were identified with autism, while in California the figure reached 5.3%, or about 1 in 19 children. These gaps likely reflect differences in access to diagnostic services, awareness among parents and clinicians, and local screening practices rather than true biological variation from state to state.
How the Rate Has Changed Over Time
When the CDC first began tracking autism prevalence in 2000, the estimate was roughly 1 in 150 children. By 2012, it had risen to 1 in 68. By 2018, it was 1 in 44. Now, at 1 in 31, the rate has more than quadrupled in just over two decades. That trajectory looks alarming at first glance, but most researchers attribute a large share of the increase to broader diagnostic criteria, better screening tools, and greater public awareness rather than a proportional rise in the actual number of autistic people.
The shift from the older DSM-IV diagnostic manual to the current DSM-5 reshaped who qualifies for a diagnosis. Studies comparing the two systems found that roughly 30% of people who met the older criteria would not meet the newer ones, because DSM-5 consolidated several separate diagnoses (like Asperger’s syndrome) into one umbrella category while also tightening some requirements. At the same time, the broader cultural understanding of autism has led to more evaluations, particularly among groups that were historically underdiagnosed.
Autism in Adults
A 2017 CDC study estimated that 2.21% of U.S. adults have autism. That number is almost certainly an undercount. Many adults on the spectrum were never evaluated as children, especially those who developed strong coping strategies or whose traits were attributed to shyness, anxiety, or personality quirks. Women and people from marginalized communities are particularly likely to have been missed. As awareness grows, a wave of adults in their 30s, 40s, and beyond are now pursuing and receiving first-time diagnoses.
Gender Differences Are Narrowing
Autism has long been described as far more common in boys than girls, with older data suggesting a ratio of about 4 to 1. That gap is shrinking fast. A large population-based study published in The BMJ found that the male-to-female ratio holds at roughly 3 to 1 for children under 10 but drops significantly in older age groups. For teenagers and young adults diagnosed between 2020 and 2022, the ratio was essentially even. Among individuals born from 2000 onward and followed to age 15 or older, girls and women were being diagnosed at the same rate as boys and men.
By the study’s projections, the cumulative male-to-female ratio at age 20 was expected to reach full parity by 2024. This shift is driven largely by increased recognition that autism presents differently in girls, who are more likely to mask their traits socially. Clinicians are now better at identifying these subtler presentations, which means many girls and women who would have been overlooked a decade ago are now getting diagnoses.
Global Estimates
The World Health Organization estimates that about 1 in 127 people worldwide had autism as of 2021. That figure sits well below the U.S. rate, but the difference reflects access to diagnostic infrastructure more than anything biological. Countries with robust screening programs and well-funded developmental pediatrics consistently report higher prevalence. In many low- and middle-income nations, autism goes largely undiagnosed, meaning millions of people live without identification or support.
Why the Numbers Keep Rising
Several forces push the prevalence figure upward simultaneously. Screening programs now reach children earlier and in more settings, including pediatric well-child visits. Schools and insurance systems have expanded eligibility criteria, creating incentives for evaluation. And cultural stigma around developmental differences, while still present, has decreased enough that more families pursue assessments.
There is also a genuine scientific question about whether some portion of the increase reflects a true rise in prevalence, potentially linked to environmental factors, parental age trends, or other influences. Researchers have not reached consensus on this, but most agree that the bulk of the measured increase comes from better detection of people who would have gone undiagnosed in earlier decades.
The Cost of Prevalence
Rising prevalence carries significant economic weight. Research estimates that autism is associated with approximately $3.6 million in lifetime social costs per person, encompassing education, healthcare, lost productivity, and support services. As the identified population grows, the demand on schools, healthcare systems, and community services grows with it. For families, the practical reality often involves long waitlists for evaluation, limited availability of therapists, and out-of-pocket expenses that insurance doesn’t fully cover.